AVEO
AVEO Pharmaceuticals, Inc.
AVEO
AVEO
Delisted
AVEO was delisted on the 19th of January, 2023.
94 hedge funds and large institutions have $119M invested in AVEO Pharmaceuticals, Inc. in 2018 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 30 increasing their positions, 13 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
31% less capital invested
Capital invested by funds: $173M → $119M (-$54.5M)
Holders
94
Holding in Top 10
1
Calls
$13.7M
Puts
$2.1M
Top Buyers
| 1 | +$11.5M | |
| 2 | +$3.21M | |
| 3 | +$3.2M | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$1.98M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.07M |
Top Sellers
| 1 | -$9.37M | |
| 2 | -$3.72M | |
| 3 | -$2.73M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$2.13M |
| 5 |
PM
Prosight Management
Dallas,
Texas
|
-$2.02M |